Number of patients | 31 |
Number of lesions | 41 |
Tumor volume on CT (cm3) | |
Median | 51.0 |
Mean ± SD | 120.9 ± 222.4 |
Range | 1.6–1,202.7 |
Tumor size on CT (cm) | |
Mean ± SD | 4.5 ± 2.5 |
Range | 1.5–10.8 |
Visual 18F-FDG uptake | |
Negative | 23 |
Positive | 18 |
TSUVmax | |
Median | 3.5 |
Mean ± SD | 3.8 ± 1.4 |
Range | 1.9–8.4 |
TSUVmean | |
Median | 2.9 |
Mean ± SD | 3.0 ± 0.9 |
Range | 1.7–5.6 |
TSUVmax/LSUVmax | |
Median | 1.15 |
Mean ± SD | 1.4 ± 0.6 |
Range | 0.4–3.2 |
TSUVmax/LSUVmean | |
Median | 1.36 |
Mean ± SD | 1.6 ± 0.7 |
Range | 0.5–3.8 |
CT/18F-FDG PET score | |
≤4 | 16 |
>4 | 25 |
SABR dose (Gy) | |
Median | 42 |
Mean ± SD | 41.4 ± 6 |
Range | 30–50 |
SABR dose per fraction (Gy) | |
Median | 9 |
Range | 6–12 |